# Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety

> **NCT06284668** · NA · COMPLETED · sponsor: **Tianjin Medical University General Hospital** · enrollment: 315 (actual)

## Conditions studied

- Sleep Disturbance

## Interventions

- **DRUG:** normal Saline
- **DRUG:** Esketamine
- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT06284668
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-04
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-05-20
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06284668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06284668, "Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06284668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*